Table of Contents
Pharmaceutical company registration in Nepal presents a significant business opportunity as demand for medicines continues to grow, imports are rising, and the government actively supports local drug manufacturing. However, the pharmaceutical sector is heavily regulated, requiring multiple approvals from the Department of Drug Administration (DDA), Office of Company Registrar (OCR), and Department of Industry (DOI). This comprehensive guide covers every aspect of registering a pharmaceutical company in Nepal, including licensing requirements, documentation, GMP standards, investment rules, and compliance obligations under the Drug Act 2035 and related regulations.
Legal Framework for Pharmaceutical Companies
The pharmaceutical industry in Nepal operates under a comprehensive legal framework that ensures the safety, efficacy, and quality of medicines available to the public:
| Legislation/Regulation | Year | Scope |
|---|---|---|
| Drug Act (Aushadhi Ain) | 2035 (1978) | Primary law governing manufacture, sale, distribution, import, and export of drugs |
| Drug Registration Regulation | 2038 (1981) | Specific requirements and procedures for drug registration |
| Drug Standard Regulation | 2043 (1986) | Standards for drug quality, packaging, and labeling |
| Company Act | 2063 (2006) | Company incorporation and registration (Section 3) |
| Industrial Enterprises Act | 2076 (2019) | Industrial registration and environmental requirements (Sections 4, 5, 7) |
| National Drug Policy | 1995 | Guidelines for ensuring availability of safe, effective, quality drugs |
| GMP Guidelines | Various | Good Manufacturing Practice standards for pharmaceutical manufacturing |
| Codes of Pharmaceutical Marketing Practices | 2007 | Marketing practices regulation for pharmaceutical companies |
Regulatory Authorities for Pharmaceutical Companies
Multiple government agencies are involved in the registration and oversight of pharmaceutical companies in Nepal:
| Authority | Location | Role |
|---|---|---|
| Department of Drug Administration (DDA) | Bijulibazar, Kathmandu | Primary regulatory body for pharmaceuticals; issues manufacturing licenses, product registration, import/export permits |
| Office of Company Registrar (OCR) | Tripureshwor, Kathmandu | Company incorporation and registration |
| Department of Industry (DOI) | Tripureshwor, Kathmandu | Industrial license for manufacturing-scale operations |
| Ministry of Health and Population | Ramshahpath, Kathmandu | Policy oversight and standards |
| Inland Revenue Department (IRD) | Lazimpat, Kathmandu | Tax registration (PAN/VAT) |
| Municipality/Rural Municipality | Local offices | Local business operating license and ward registration |
| Drug Research Laboratory | Government operated | Scientific research, testing, and analysis of drugs |
Types of Pharmaceutical Businesses in Nepal
Before registering, you must determine which type of pharmaceutical business you intend to operate, as requirements differ significantly:
| Business Type | Description | Key Requirements | Complexity |
|---|---|---|---|
| Drug Manufacturing Company | Produces pharmaceutical products (tablets, capsules, syrups, injections, etc.) | GMP-compliant factory, QC lab, manufacturing license, product registration | High |
| Drug Import Company | Imports medicines from foreign manufacturers | Import license, product registration for each imported drug, temperature-controlled storage | Medium |
| Wholesale Distribution Company | Distributes medicines to retailers and healthcare facilities | Wholesale license, warehouse facility, cold chain (if needed) | Medium |
| Retail Pharmacy | Sells medicines directly to consumers | Retail license, registered pharmacist, proper storage | Low |
| Drug Export Company | Exports locally manufactured medicines | Export recommendation letter, product registration, quality certification | Medium-High |
Pre-Registration Requirements
Before initiating the registration process, ensure you have the following prerequisites in place:
Basic Requirements
- Clear Business Plan: Define whether you will manufacture, import, wholesale, or operate retail pharmacy
- Qualified Technical Person: Registered pharmacist or chemist with valid Nepal Pharmacy Council registration
- Valid Factory Location/Space: Suitable premises meeting DDA infrastructure requirements
- Environmental Compliance Planning: Prepare for IEE or EIA requirements
- Adequate Financial Investment: Sufficient capital for infrastructure, equipment, and operations
- Human Resources Planning: Identify key personnel including production manager, QC head, and quality assurance personnel
Infrastructure Requirements (For Manufacturing)
- GMP-compliant production facility
- Quality control laboratory with testing equipment
- Adequate storage areas with temperature and humidity control
- Clean room facilities meeting specified standards
- Water treatment and purification systems
- HVAC (Heating, Ventilation, and Air Conditioning) systems
- Waste disposal and effluent treatment systems
- Safety equipment and fire prevention systems
Step-by-Step Registration Process for Manufacturing Company
Step 1: Company Registration at OCR
Register the company as a Private Limited Company or Public Limited Company (for large-scale manufacturing) at the Office of Company Registrar:
- Name Reservation: Reserve company name at OCR (valid for 35 days)
- Prepare MOA & AOA: Draft Memorandum and Articles of Association clearly mentioning pharmaceutical manufacturing/distribution objectives
- Submit Documents: Company registration application with required documents
- Pay Registration Fees: Based on authorized capital
- Obtain Certificate: Receive Certificate of Incorporation
Documents Required for Company Registration
- Memorandum of Association (MOA)
- Articles of Association (AOA)
- Citizenship certificates of all shareholders
- Passport-size photographs of shareholders
- Proposed registered office address and lease agreement
- Shareholder consent letters
- Share subscription forms
- Bank voucher for capital deposit
Step 2: Ward Office and Tax Registration
- Ward Registration: Register at local ward office for business operating license
- PAN Registration: Obtain Permanent Account Number from Inland Revenue Office
- VAT Registration: Register for Value Added Tax if turnover exceeds threshold
Step 3: Obtain Recommendation Letter from DDA
Under Drug Act 2035 Section 7 and Drug Registration Regulation 2038 Rule 3, obtain a recommendation letter from DDA to establish a drug manufacturing industry:
- Submit application to DDA
- Provide preliminary project details
- Demonstrate technical capability
- Obtain recommendation letter for industry establishment
Step 4: Industrial Registration at DOI
Under Industrial Enterprises Act 2076 Sections 4 and 5, register the pharmaceutical company as an industry at the Department of Industry:
- Submit application with feasibility study report
- Provide company registration certificate
- Submit DDA recommendation letter
- Obtain industrial registration certificate
Step 5: Environmental Compliance (IEE/EIA)
Under Industrial Enterprises Act 2076 Section 7 and Environmental Protection Act, complete environmental assessment:
- Initial Environmental Examination (IEE): Required for medium-scale manufacturing
- Environmental Impact Assessment (EIA): Required for large-scale manufacturing with significant environmental impact
Step 6: Secure Location and Infrastructure Approval
The factory location and building must meet:
- Environmental standards and pollution control requirements
- Proper drainage and waste management systems
- Safety exit plans and fire prevention measures
- Adequate space for production, storage, QC lab, and administration
- Compliance with local building codes and zoning regulations
Step 7: Prepare Factory Layout and GMP Documentation
Prepare comprehensive factory layout following cGMP (current Good Manufacturing Practice) standards and WHO guidelines:
| Document | Description |
|---|---|
| Factory Layout Plan | Detailed floor plans showing production flow, personnel flow, material flow |
| Clean Room Design | Specifications for classified areas, air locks, pressure differentials |
| HVAC System Details | Heating, ventilation, air conditioning specifications and validation |
| Water Treatment System | Purified water and water for injection system specifications |
| Machinery List | Complete list of manufacturing and QC equipment with specifications |
| Standard Operating Procedures (SOPs) | Documented procedures for all operations |
| Quality Policies | Quality management system documentation |
| QC Lab Setup Documents | Laboratory layout, equipment list, testing procedures |
| Staff Qualifications | Credentials of key personnel including pharmacists and chemists |
Step 8: Submit Manufacturing License Application to DDA
Under Drug Act 2035 Section 9 and Drug Registration Regulation 2038 Rule 5, submit application for manufacturing license (product license) to DDA:
Required Documents
- Application form for pharmaceutical company registration
- Company registration certificate
- Industrial registration certificate from DOI
- IEE/EIA approval certificate
- Factory layout approved by architect
- Site master file
- GMP compliance documentation
- Quality control protocols
- List of proposed products
- Pharmacist registration certificates
- Staff qualifications and organizational structure
- Proof of capital investment
- Land ownership or lease documents
- Machinery and equipment list
- Water and HVAC system specifications
Step 9: DDA Inspection
DDA officials conduct comprehensive inspection of:
- Production Area: Clean rooms, processing areas, filling areas
- Storage Facilities: Raw material, finished goods, rejected materials warehouses
- Quality Control Laboratory: Equipment, reagents, reference standards, documentation
- Waste Disposal: Effluent treatment, solid waste management
- Safety Equipment: Fire extinguishers, safety showers, first aid facilities
- Documentation: SOPs, batch records, validation documents
- Personnel: Training records, qualifications, hygiene practices
Step 10: Receive Manufacturing License
Upon successful inspection and verification, DDA issues the manufacturing license. The license is valid for one year and must be renewed annually.
Important: All licenses, recommendation letters, and certificates are valid for two years from the date of issue. Renewal must be done within thirty-five days of expiry. Late renewal attracts additional fees.
Product Registration Process
Under Drug Act 2035 Section 8(2) and Drug Registration Regulation 2038 Rule 4B, every pharmaceutical product must be individually registered before sale and distribution:
Product Registration Steps
- Prepare product dossier with complete formulation details
- Submit stability data supporting proposed shelf life
- Provide bioequivalence studies (for generic products)
- Submit clinical trial data (for new drugs)
- Provide quality control specifications and test methods
- Submit product samples for laboratory testing
- Pay registration fees
- Undergo expert committee review
- Receive drug registration certificate
Documents Required for Product Registration
- Completed application form
- Product information (composition, dosage form, strength)
- Manufacturing process details
- Quality control specifications and test methods
- Stability data
- Bioequivalence studies (for generic products)
- Proposed packaging and labeling information
- Product samples
- Registration fees payment receipt
Registration Process for Import Company
For companies importing medicines rather than manufacturing:
Import License Requirements
- Company Registration: Register company at OCR with import business objectives
- Tax Registration: Obtain PAN and VAT registration
- Storage Facility: Temperature-controlled warehouse meeting DDA standards
- Qualified Personnel: Employ registered pharmacist
- DDA Registration: Register as drug importer with DDA
- Product Registration: Register each imported medicine individually
- Import Recommendation Letter: Obtain recommendation for each import consignment
Documents for Import Registration
- Company registration certificate
- PAN/VAT registration
- Warehouse lease agreement or ownership documents
- Pharmacist registration certificate
- Authorization letter from foreign manufacturer
- Certificate of Pharmaceutical Product (CPP) from country of origin
- GMP certificate of manufacturing facility
- Product registration application for each drug
- Stability data relevant to Nepal's climatic conditions
Registration Process for Wholesale Distribution
Wholesale License Requirements
- Company Registration: Register company with wholesale distribution objectives
- Tax Registration: PAN and VAT registration
- Warehouse Facility: Adequate storage space meeting pharmaceutical standards
- Cold Chain: Temperature-controlled storage for temperature-sensitive products
- Qualified Personnel: Pharmacist or pharmacy technician
- DDA Approval: Wholesale distribution license
Registration for Retail Pharmacy (Drug Sales)
Under Drug Act 2035 Section 10 and Drug Registration Regulation 2038 Rule 6, retail pharmacies must obtain certificate of registration:
Retail Pharmacy Requirements
- Register company or firm at OCR
- Obtain ward office registration
- Tax registration (PAN)
- Obtain DDA recommendation letter
- Register name and shop/firm with DDA
- Obtain certificate of registration for selling and distributing drugs
- Employ registered pharmacist or pharmacy assistant
Note: Retail pharmacies can only sell and distribute registered drugs. Selling unregistered or date-expired drugs is prohibited under Section 30 of the Drug Act.
Drug Advertisement License
Under Drug Act 2035 Section 19 and Drug Registration Regulation 2038 Rule 7, any person intending to advertise a drug must obtain a license from DDA:
- Submit application for advertisement license
- Provide details of advertisement content
- Ensure compliance with Codes of Pharmaceutical Marketing Practices 2007
- No false or misleading claims about drug use, utility, or efficacy
Good Manufacturing Practice (GMP) Requirements
All pharmaceutical manufacturing companies must comply with GMP standards:
Key GMP Requirements
| GMP Area | Requirements |
|---|---|
| Personnel | Qualified staff, training programs, hygiene requirements, defined responsibilities |
| Premises | Suitable location, adequate space, proper layout, environmental controls |
| Equipment | Appropriate design, proper installation, regular maintenance, calibration |
| Documentation | SOPs, batch records, specifications, validation protocols, change control |
| Production | Validated processes, in-process controls, batch documentation |
| Quality Control | Sampling, testing, stability studies, reference standards, retained samples |
| Quality Assurance | Quality management system, audits, CAPA, complaints handling |
| Storage & Distribution | Proper storage conditions, inventory control, distribution records |
Timeline for Pharmaceutical Company Registration
| Stage | Duration | Authority |
|---|---|---|
| Company Registration | 2-4 weeks | OCR |
| Tax Registration | 1-2 weeks | IRD |
| DDA Recommendation Letter | 2-4 weeks | DDA |
| Industrial Registration | 4-6 weeks | DOI |
| IEE/EIA Approval | 4-8 weeks | Ministry of Environment |
| Infrastructure Setup | 3-12 months | Company |
| DDA Inspection & Manufacturing License | 8-12 weeks | DDA |
| Product Registration (per product) | 6-12 months | DDA |
| Total (Manufacturing) | 6-18 months | - |
| Total (Import/Wholesale) | 3-6 months | - |
Cost of Pharmaceutical Company Registration
| Cost Category | Estimated Amount (NPR) | Remarks |
|---|---|---|
| Company Registration Fee | 5,000 – 50,000 | Based on authorized capital |
| Industrial Registration Fee | 10,000 – 50,000 | Based on scale of industry |
| DDA Registration Fee (Manufacturer) | 100,000 | One-time registration |
| IEE/EIA Costs | 50,000 – 500,000 | Depends on project scale |
| Infrastructure Setup | 10,000,000 – 100,000,000+ | Factory, equipment, QC lab |
| GMP Compliance Setup | 5,000,000 – 20,000,000 | Clean rooms, HVAC, documentation |
| Product Registration (per product) | 10,000 – 50,000 | Varies by product type |
| Legal and Consultancy Fees | 100,000 – 500,000 | Professional advisory services |
| DDA Inspection Fees | 25,000 – 100,000 | Per inspection |
| Total (Small-Medium Manufacturing) | 20,000,000 – 50,000,000+ | Excluding land costs |
| Total (Import Company) | 500,000 – 2,000,000 | Excluding warehouse costs |
Post-Registration Compliance Requirements
After registration, pharmaceutical companies must maintain ongoing compliance:
Annual Compliance Obligations
- License Renewal: Renew manufacturing/import license annually
- DDA Inspections: Allow periodic inspections by DDA officials
- GMP Compliance: Maintain continuous GMP compliance
- Lot Release Certificates: Obtain for each batch manufactured
- Product Testing: Regular quality testing and stability studies
- Tax Filings: Annual tax returns and audit reports
- Periodic Reports: Submit production, sales, and quality reports to DDA
Pharmacovigilance Requirements
- Establish system for monitoring adverse drug reactions
- Report adverse events to DDA promptly
- Maintain post-marketing surveillance records
- Recall products if found unsafe or not meeting quality standards
Quality Standards Compliance
- Products must meet Nepalese Pharmacopoeia or internationally recognized standards
- Maintain quality throughout shelf life
- Proper labeling including composition, dosage, expiry date, and side effects
- Safe storage of narcotic and poisonous drugs with record-keeping
Prohibitions and Penalties
The Drug Act 2035 establishes strict prohibitions and penalties:
| Prohibition | Section | Penalty |
|---|---|---|
| Operating without adequate human resources/materials | Section 28 | Imprisonment up to 3 years and/or fine up to NPR 25,000 |
| Adulteration of drugs or selling adulterated drugs | Section 29 | Imprisonment up to 3 years and/or fine up to NPR 25,000 |
| Selling date-expired drugs | Section 30 | Imprisonment up to 3 years and/or fine up to NPR 25,000 |
| Conducting clinical trials without license | Section 31 | Imprisonment up to 3 years and/or fine up to NPR 25,000 |
| False/misleading drug advertising | Section 19 | License cancellation and penalties |
| Selling unregistered drugs | Various | License cancellation, fines, seizure |
Liability: Manufacturers are held responsible for any harm caused by drugs that fail to meet safety, efficacy, and quality standards. They must provide compensation to individuals who suffer injury or death due to such drugs.
Benefits of Registering a Pharmaceutical Company in Nepal
- Growing Market: Nepal's pharmaceutical sector is expanding rapidly with increasing healthcare awareness
- Government Support: Policies encouraging domestic pharmaceutical production and import substitution
- Regional Market Access: Strategic location providing access to India, China, and South Asian markets
- Skilled Workforce: Pool of qualified pharmacists and healthcare professionals
- Legal Recognition: Official status to operate in the regulated pharmaceutical sector
- Funding Opportunities: Access to loans and investments for registered companies
- Export Potential: Opportunities to export to neighboring countries
- IP Protection: Ability to protect formulations and brands through proper registration
Summary: Registration Process Flowchart
| Step | For Manufacturing | For Sale/Distribution | Legal Provision |
|---|---|---|---|
| 1 | Company Registration at OCR + Ward Registration + Tax Registration | Company Act 2063 (Sec 3) | |
| 2 | Recommendation letter from DDA to establish drug industry | Drug Act 2035 (Sec 7), Regulation 2038 (Rule 3) | |
| 3 | Registration of Pharmaceutical Company at Department of Industry | Industrial Enterprises Act 2076 (Sec 4, 5) | |
| 4 | Initial Environmental Examination (IEE) or EIA | Industrial Enterprises Act 2076 (Sec 7) | |
| 5 | Obtain product license (manufacturing plant layout approval) | Registration prior to importation of drugs | Drug Act 2035 (Sec 9), Regulation 2038 (Rule 5) |
| 6 | Registration of drugs prior to sale and distribution | Drug Act 2035 (Sec 8(2)), Regulation 2038 (Rule 4B) | |
| 7 | Obtain certificate of registration for shop/firm selling drugs | Drug Act 2035 (Sec 10), Regulation 2038 (Rule 6) | |
| 8 | Obtain license for drug advertisement (if applicable) | Drug Act 2035 (Sec 19), Regulation 2038 (Rule 7) | |
Need Legal Assistance?
Our legal team provides comprehensive services for pharmaceutical company registration including DDA licensing, product registration, GMP compliance documentation, and ongoing regulatory support. Contact us for professional consultation on pharmaceutical business registration in Nepal.
Frequently Asked Questions
The primary law governing pharmaceuticals in Nepal is the Drug Act 2035 (1978), which regulates the manufacture, sale, distribution, import, and export of drugs. Supporting regulations include the Drug Registration Regulation 2038 (1981) for registration procedures, Drug Standard Regulation 2043 (1986) for quality standards, Company Act 2063 for company incorporation, and Industrial Enterprises Act 2076 for industrial registration. The Department of Drug Administration (DDA) under the Ministry of Health and Population oversees all pharmaceutical activities.
Multiple authorities are involved:
| Authority | Role |
|---|---|
| Office of Company Registrar (OCR) | Company incorporation |
| Department of Drug Administration (DDA) | Primary regulator, licensing, product registration |
| Department of Industry (DOI) | Industrial registration for manufacturing |
| Inland Revenue Department (IRD) | Tax registration (PAN/VAT) |
| Ministry of Health & Population | Policy oversight |
| Municipality/Ward Office | Local business license |
Pharmaceutical businesses in Nepal include drug manufacturing companies (producing tablets, capsules, syrups, injections), drug import companies (importing medicines from abroad), wholesale distribution companies (distributing to retailers and healthcare facilities), retail pharmacies (selling directly to consumers), and export companies (exporting locally manufactured medicines). Each type has different licensing requirements and complexity levels.
Pre-registration requirements include:
- Clear business plan defining operations (manufacturing/import/wholesale/retail)
- Qualified technical person (registered pharmacist or chemist)
- Valid factory location meeting DDA infrastructure requirements
- Environmental compliance planning for IEE/EIA
- Adequate financial investment
- Human resources planning for key positions
- For manufacturing: GMP-compliant facility, QC laboratory, clean rooms, HVAC systems
Step 1: Company registration at OCR (Private/Public Limited)
Step 2: Ward office and tax registration (PAN/VAT)
Step 3: Obtain recommendation letter from DDA (Drug Act Section 7)
Step 4: Industrial registration at DOI (Industrial Enterprises Act Section 4-5)
Step 5: Environmental compliance (IEE/EIA)
Step 6: Secure location and infrastructure approval
Step 7: Prepare factory layout and GMP documentation
Step 8: Submit manufacturing license application to DDA
Step 9: DDA inspection
Step 10: Receive manufacturing license
Required documents include:
- Application form
- Company registration certificate
- Industrial registration certificate
- IEE/EIA approval
- Factory layout (architect approved)
- Site master file
- GMP compliance documentation
- Quality control protocols
- List of proposed products
- Pharmacist registration certificates
- Staff qualifications
- Capital proof
- Land ownership/lease documents
- Machinery list
- HVAC and water system specifications
| Stage | Duration |
|---|---|
| Company Registration | 2-4 weeks |
| Tax Registration | 1-2 weeks |
| DDA Recommendation | 2-4 weeks |
| Industrial Registration | 4-6 weeks |
| IEE/EIA Approval | 4-8 weeks |
| Infrastructure Setup | 3-12 months |
| DDA Inspection & License | 8-12 weeks |
| Product Registration | 6-12 months per product |
| Total (Manufacturing) | 6-18 months |
| Total (Import) | 3-6 months |
GMP requirements cover:
- Personnel: Qualified staff, training, hygiene, defined responsibilities
- Premises: Suitable location, adequate space, environmental controls
- Equipment: Proper design, installation, maintenance, calibration
- Documentation: SOPs, batch records, specifications, validation
- Production: Validated processes, in-process controls
- Quality Control: Testing, stability studies, reference standards
- Quality Assurance: Management system, audits, CAPA
- Storage & Distribution: Proper conditions, inventory control
Requirements for import company:
- Company registration at OCR with import objectives
- PAN/VAT registration
- Temperature-controlled warehouse meeting DDA standards
- Employ registered pharmacist
- Register as drug importer with DDA
- Register each imported medicine individually
- Obtain import recommendation letter for each consignment
- Provide CPP from country of origin and manufacturer authorization
Product registration under Drug Act Section 8(2):
- Prepare product dossier with formulation details
- Submit stability data supporting shelf life
- Provide bioequivalence studies (generics) or clinical data (new drugs)
- Submit quality control specifications and test methods
- Submit product samples for laboratory testing
- Pay registration fees
- Undergo expert committee review
- Receive drug registration certificate Duration: 6-12 months per product
| Cost Category | Amount (NPR) |
|---|---|
| Company Registration | 5,000 – 50,000 |
| Industrial Registration | 10,000 – 50,000 |
| DDA Registration (Manufacturer) | 100,000 |
| IEE/EIA | 50,000 – 500,000 |
| Infrastructure Setup | 10M – 100M+ |
| GMP Compliance | 5M – 20M |
| Product Registration (per product) | 10,000 – 50,000 |
| Legal/Consultancy | 100,000 – 500,000 |
| Total (Manufacturing) | 20M – 50M+ |
Post-registration requirements include:
- Annual license renewal
- Periodic DDA inspections
- Continuous GMP compliance
- Lot release certificates for each batch
- Regular quality testing and stability studies
- Tax filings and audit reports
- Production, sales, and quality reports to DDA
- Pharmacovigilance and adverse event reporting
- Product recall if quality issues found
- Compliance with pharmacopoeial standards
Penalties under Drug Act 2035:
- Operating without adequate resources: Up to 3 years imprisonment and/or NPR 25,000 fine
- Adulteration or selling adulterated drugs: Up to 3 years imprisonment and/or NPR 25,000 fine
- Selling expired drugs: Up to 3 years imprisonment and/or NPR 25,000 fine
- Clinical trials without license: Up to 3 years imprisonment and/or NPR 25,000 fine
- False advertising: License cancellation
- Manufacturers liable for compensation for harm caused by substandard drugs
Yes, foreign companies can register pharmaceutical businesses in Nepal through joint ventures or subsidiaries. Requirements include compliance with Foreign Investment and Technology Transfer Act (FITTA), necessary approvals from DDA, DOI, and other authorities. Foreign pharmaceutical products can be registered with CPP from country of origin, manufacturer authorization, GMP certificate, and meeting Nepalese regulatory requirements. Local agent appointment is typically required.
15. What is the validity period for pharmaceutical licenses and how to renew? All licenses, recommendation letters, and certificates are valid for two years from date of issue. Manufacturing licenses require annual renewal. Renewal must be done within 35 days of expiry:
- Submit renewal application before expiration
- Provide updated documentation and post-marketing surveillance data
- Pay renewal fees
- Undergo re-evaluation if required
- Receive renewed certificate Late renewal attracts additional fees. Failure to renew results in inability to legally operate.
